These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7835205)

  • 21. Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
    Murata GH; Shah JH; Duckworth WC; Wendel CS; Mohler MJ; Hoffman RM
    J Am Diet Assoc; 2004 Dec; 104(12):1816-26. PubMed ID: 15565075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of adherence to antiretroviral medications.
    Paterson DL; Potoski B; Capitano B
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S103-6. PubMed ID: 12562030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of non-insulin-dependent diabetes mellitus in the elderly.
    Ruoff G
    J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of medication adherence in patients with type 2 diabetes mellitus.
    Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ
    Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical and analytic issues in the electronic assessment of adherence.
    Cook P; Schmiege S; McClean M; Aagaard L; Kahook M
    West J Nurs Res; 2012 Aug; 34(5):598-620. PubMed ID: 22101392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPs' perspectives of type 2 diabetes patients' adherence to treatment: A qualitative analysis of barriers and solutions.
    Wens J; Vermeire E; Royen PV; Sabbe B; Denekens J
    BMC Fam Pract; 2005 May; 6(1):20. PubMed ID: 15890071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone.
    Kalichman SC; Amaral CM; Stearns H; White D; Flanagan J; Pope H; Cherry C; Cain D; Eaton L; Kalichman MO
    J Gen Intern Med; 2007 Jul; 22(7):1003-6. PubMed ID: 17390095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators.
    Zeller A; Ramseier E; Teagtmeyer A; Battegay E
    Hypertens Res; 2008 Nov; 31(11):2037-43. PubMed ID: 19098375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
    Hanif W; Malik W; Hassanein M; Kamal A; Geransar P; Andrews C; Azam M; Barnett AH
    Curr Med Res Opin; 2013 Jul; 29(7):807-11. PubMed ID: 23659561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Insulin receptors in diabetes mellitus].
    Tankova Ts
    Vutr Boles; 1989; 28(6):8-12. PubMed ID: 2699128
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH; Lowy C; Perkins JR; Lim HS
    Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes mellitus. Aspects of complications and treatment.
    Wolffenbuttel BH
    Neth J Med; 1993 Oct; 43(3-4):187-99. PubMed ID: 8302399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus.
    Gibson JM; Westwood M; Crosby SR; Gordon C; Holly JM; Fraser W; Anderson C; White A; Young RJ
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1369-75. PubMed ID: 7536208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
    Klein W
    Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
    Heisler M; Hogan MM; Hofer TP; Schmittdiel JA; Pladevall M; Kerr EA
    Circulation; 2008 Jun; 117(22):2884-92. PubMed ID: 18506011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined insulin-sulfonylurea treatment of type II diabetes.
    Bingham PR; Riddle MC
    Diabetes Educ; 1989; 15(5):450-5. PubMed ID: 2673707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of anticonvulsant adherence behaviour in the community using a Medication Events Monitoring System (MEMS).
    Rivers PH; Ardagh-Walter N; Wright EC
    Health Care Anal; 1998 Dec; 6(4):308-16. PubMed ID: 10345937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship among social support, treatment adherence and metabolic control of diabetes mellitus patients.
    Gomes-Villas Boas LC; Foss MC; Freitas MC; Pace AE
    Rev Lat Am Enfermagem; 2012; 20(1):52-8. PubMed ID: 22481721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.